Story
WW International Stock Jumps on Google Health Partnership

Summary
Shares of WW International surged over 10% after the company announced a collaboration with Google Health Enterprise to integrate Fitbit technology into its corporate wellness programs.
WW International (NASDAQ: WW) stock surged 10.4% in pre-open trading after the company announced a new collaboration with Google Health Enterprise. The partnership aims to integrate Google's wearable technology into Weight Watchers' employer-sponsored wellness programs.
The Google Partnership
The agreement combines Google's hardware and software ecosystem with WW's established corporate client base. Under the terms, eligible members of select Weight Watchers for Business accounts will gain access to a Google Fitbit Air and Google Health Premium upon meeting specific program activity requirements.
This strategic move positions WW as a technology-forward partner in the growing corporate health benefits market, expanding its addressable market and modernizing its offering for employers.
Market Reaction and Technicals
The announcement provided a significant catalyst for the stock, which had traded as high as $15.13 in the prior session before extending its gains pre-market. The rally lifts the shares well above their 52-week low of $8.37.
AdFrom a technical perspective, the move is notable as WW's shares crossed decisively above their 200-day moving average. This long-term trend indicator had previously acted as a significant resistance level, and a sustained break above it is often viewed by traders as a bullish signal.
Investor and Market Context
The rally is also supported by signs of growing institutional interest and a favorable market backdrop. Recent data showed that Cygnus Capital Advisors nearly doubled its position in WW during the second quarter, while Bank of New York Mellon initiated a new stake, suggesting rising conviction among large investors.
Furthermore, the broader market saw capital rotating into technology-linked stocks. WW's partnership with a major tech platform aligns the company with this narrative, providing a dual tailwind from both company-specific news and the prevailing market tone.
Read next
More on Stocks
Iovance Biotherapeutics Lifts 2026 Revenue Outlook, Shares Jump
The biotechnology firm raised its full-year revenue guidance to between $410 million and $420 million, beating analyst estimates and citing strong demand for its cancer therapies.

JPMorgan Downgrades Monday.com to Neutral on Slowing Customer Growth
The investment bank lowered its rating on the work management software company, citing a decline in new recurring revenue and longer sales cycles among smaller businesses.

Insider Transactions: Meta, CrowdStrike CEOs Sell Stock; Executives Buy into REITs and Biotechs
Recent SEC filings show multi-million dollar stock sales by executives at Meta and CrowdStrike, mostly under pre-set plans, while leaders at Angel Oak Mortgage REIT and Inhibrx Biosciences made significant open-market purchases.

Plug Power Shares Rise on 280 MW Electrolyzer Deal for Danish Green Fuel Project
Plug Power has secured a major agreement to supply 280 MW of electrolyzers to Arcadia eFuels for a sustainable aviation fuel project in Denmark, causing its stock to climb in premarket trading.